Becton, Dickinson and Company (LON:0R19)

Market Cap	41.83B
Revenue (ttm)	16.25B
Net Income (ttm)	1.25B
Shares Out	n/a
EPS (ttm)	4.33
PE Ratio	33.51
Forward PE	12.94
Dividend	3.15 (1.63%)
Ex-Dividend Date	Sep 8, 2025

Volume	2,213
Average Volume	973
Open	193.49
Previous Close	194.33
Day's Range	191.48 - 195.09
52-Week Range	162.29 - 251.08
Beta	0.30
RSI	59.13
Earnings Date	Nov 6, 2025

About LON:0R19

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1897
• Employees: 72,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R19

Financial Performance

In 2025, LON:0R19's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD